verified99%+ Verified Purity
local_shippingFast EU Delivery (through resellers)
Myotrope
Homechevron_rightAll Peptideschevron_rightIpamorelin Injection Pen
Ipamorelin Injection Pen
verified_user

Safety data sheet

Standardized safety protocols and material specifications for professional use.

analytics

Certificate of Analysis

Purity verified via High-Performance Liquid Chromatography (HPLC) for #myo-ipamorelin-injection-pen-10mg

Official Product Data Sheet

Ipamorelin Injection Pen (10mg)

High >98% Purity

Vial Contents
10 mg Ipamorelin (3 mL pre-filled injection pen)
Includes
Ready-to-use multi-dose injection pen — no mixing required
Form
Pre-filled multi-dose pen
Purity
≥98%, third-party verified
Sequence
Growth Hormone Secretagogue
Molecular Formula
See chemical properties
Molecular Mass
711.85 g/mol
CAS No.
170851-70-4
Solubility
Concentration: ≈3.33 mg/mL | Per click: 1 unit ≈ 33.33 mcg (0.033 mg)
Storage
Refrigerate at 2–8 °C. Protect from light. Do not freeze.

Authorized Resellers

Available through our trusted partners

12
verifiedVerified

123peptide.com

Netherlands · Europe

local_shipping2-3 Business Days

Buy from Partneropen_in_new
DE
verifiedVerified

Depeptidenwinkel.com

Netherlands · Europe

local_shipping2-3 Business Days

Buy from Partneropen_in_new
View all authorized resellersshopping_cart
swipe_rightSwipe to see all tabs

Scientific Background

Ipamorelin is a highly selective growth hormone secretagogue that activates ghrelin/GHS receptors to stimulate pulsatile GH release without affecting cortisol, prolactin, or ACTH. The 10 mg pen at ≈3.33 mg/mL provides double the per-pen economy compared to the 5 mg format — ideal for extended 12–16 week GH research protocols.

Intended Research Use

  • Selective GHS receptor activation research
  • Extended pulsatile GH secretion studies
  • Body composition and recovery research
  • Long-cycle GH axis protocols (12–16+ weeks)

menu_bookScientific Publications

article

Eur J Endocrinol (1998)

Ipamorelin, the first selective growth hormone secretagogue

open_in_newhttps://pubmed.ncbi.nlm.nih.gov/9849822/

warning

FOR RESEARCH USE ONLY. This product is intended for laboratory research purposes only and is not for human consumption, medical, or diagnostic use.

Myotrope

Possible stacks with other peptides

Synergistic combinations for enhanced research outcomes

Ipamorelin's GHRP activity pairs synergistically with GHRH analogs for amplified GH release.

CJC-1295 (no DAC)

CJC-1295 (no DAC) (2mg vial)

arrow_forward

myo-cjc-1295-no-dac-2mg

Classic GHRH + GHRP synergy — complementary receptor activation for amplified pulsatile GH release.

BPC-157 10mg

BPC-157 10mg (10mg vial)

arrow_forward

myo-bpc-157-10mg

Synergistic tissue repair and anti-inflammatory benefits alongside Ipamorelin's GH-driven recovery.

GHK-Cu 50mg

GHK-Cu 50mg (50mg vial)

arrow_forward

myo-ghk-cu-50mg

Skin regeneration and cellular health support alongside GH-driven tissue remodeling.

schedule

Cycling Note: Typical protocol: 12–16 weeks on, 4 weeks off. Monitor IGF-1 at 4–6 week intervals.

Also Available

Ipamorelin 5mg
Vial

Ipamorelin

5mg

Ipamorelin 10mg
Vial

Ipamorelin

10mg

Ipamorelin Injection Pen 5mg
Pen

Ipamorelin Injection Pen

5mg